Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bioharvest Sciences (BHST) Notes Payables (2024 - 2025)

Bioharvest Sciences has reported Notes Payables over the past 2 years, most recently at $149000.0 for Q4 2025.

  • For Q4 2025, Notes Payables fell 96.18% year-over-year to $149000.0; the TTM value through Dec 2025 reached $149000.0, down 96.18%, while the annual FY2025 figure was $149000.0, 96.18% down from the prior year.
  • Notes Payables was $149000.0 for Q4 2025 at Bioharvest Sciences, down from $3.7 million in the prior quarter.
  • Across five years, Notes Payables topped out at $7.5 million in Q1 2025 and bottomed at $149000.0 in Q4 2025.